Synergy Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal diseases and disorders, today announced that its President and CEO, Gary S. Jacob, Ph.D., will present at the Canaccord Genuity 33rd Annual Growth Conference being held at the Intercontinental Hotel in Boston, MA. The presentation is scheduled for Wednesday, August 14th at 4:00 p.m. (EDT).
Help employers find you! Check out all the jobs and post your resume.
Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal diseases and disorders, today announced that its President and CEO, Gary S. Jacob, Ph.D., will present at the Canaccord Genuity 33rd Annual Growth Conference being held at the Intercontinental Hotel in Boston, MA. The presentation is scheduled for Wednesday, August 14th at 4:00 p.m. (EDT).
Help employers find you! Check out all the jobs and post your resume.